Detail Information of Xenobiotics
| General Information of Xenobiotics (ID: XEO00594) | ||||||
|---|---|---|---|---|---|---|
| Xenobiotics Name |
SNX-001
|
|||||
| Xenobiotics Type |
Pharmaceutical Agent(s)
|
|||||
| Classification |
Drug in Phase 2 Clinical Trial
|
|||||
| Structure |
<iframe style="width: 300px; height: 300px;" frameborder="0" src="https://embed.molview.org/v1/?mode=balls&cid=11207"></iframe>
|
 |
||||
| 3D MOL | 2D MOL | |||||
| PubChem CID | ||||||
| DME(s) Modulated by This Xenobiotics | ||||||
| DME(s) Inhibited by This Xenobiotics | ||||||
| Butyrylcholine esterase (BCHE) | DME Info | Homo sapiens | [1] | |||
| References | ||||||
| 1 | Metformin suppresses CYP1A1 and CYP1B1 expression in breast cancer cells by down-regulating aryl hydrocarbon receptor expression. Toxicol Appl Pharmacol. 2014 Oct 1;280(1):138-48. | |||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.